169 related articles for article (PubMed ID: 31215654)
1. Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63-linked polyubiquitin chains.
Jin C; Kim S; Kang H; Yun KN; Lee Y; Zhang Y; Kim Y; Kim JY; Han K
J Neurochem; 2019 Sep; 150(6):776-786. PubMed ID: 31215654
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of Lys63-linked polyubiquitination in neuronal excitatory postsynapses.
Kim S; Zhang Y; Jin C; Lee Y; Kim Y; Han K
Arch Pharm Res; 2019 Apr; 42(4):285-292. PubMed ID: 30259348
[TBL] [Abstract][Full Text] [Related]
3. Increased ribosomal protein levels and protein synthesis in the striatal synaptosome of Shank3-overexpressing transgenic mice.
Jin C; Lee Y; Kang H; Jeong K; Park J; Zhang Y; Kang HR; Ma R; Seong H; Kim Y; Jung H; Kim JY; Kim YK; Han K
Mol Brain; 2021 Feb; 14(1):39. PubMed ID: 33622379
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity.
Ma Q; Ruan H; Peng L; Zhang M; Gack MU; Yao WD
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8760-E8769. PubMed ID: 28973854
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.
Zhang L; Wei N; Cui Y; Hong Z; Liu X; Wang Q; Li S; Liu H; Yu H; Cai Y; Wang Q; Zhu J; Meng W; Chen Z; Wang C
PLoS Pathog; 2018 Nov; 14(11):e1007435. PubMed ID: 30388174
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
8. Activity and circadian rhythm influence synaptic Shank3 protein levels in mice.
Sarowar T; Chhabra R; Vilella A; Boeckers TM; Zoli M; Grabrucker AM
J Neurochem; 2016 Sep; 138(6):887-95. PubMed ID: 27329942
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase CYLD regulates excitatory synaptic transmission and short-term plasticity in the hippocampus.
Chen SY; Liu KF; Tan SY; Chen XS; Li HD; Li JJ; Zhou JW; Yang L; Long C
Brain Res; 2023 May; 1806():148313. PubMed ID: 36878342
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of Shank3-overexpressing mice reveals unique molecular changes in the hypothalamus.
Jin C; Kang H; Kim S; Zhang Y; Lee Y; Kim Y; Han K
Mol Brain; 2018 Nov; 11(1):71. PubMed ID: 30482234
[TBL] [Abstract][Full Text] [Related]
11. Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism.
Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Liu S; Powell CM
Autism Res; 2016 Mar; 9(3):350-75. PubMed ID: 26559786
[TBL] [Abstract][Full Text] [Related]
12. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins.
Wooten MW; Geetha T; Babu JR; Seibenhener ML; Peng J; Cox N; Diaz-Meco MT; Moscat J
J Biol Chem; 2008 Mar; 283(11):6783-9. PubMed ID: 18174161
[TBL] [Abstract][Full Text] [Related]
13. Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in
Jin C; Kang H; Ryu JR; Kim S; Zhang Y; Lee Y; Kim Y; Han K
Front Mol Neurosci; 2018; 11():250. PubMed ID: 30233305
[TBL] [Abstract][Full Text] [Related]
14. Striatal Transcriptome and Interactome Analysis of
Lee Y; Kim SG; Lee B; Zhang Y; Kim Y; Kim S; Kim E; Kang H; Han K
Front Mol Neurosci; 2017; 10():201. PubMed ID: 28701918
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent decrease of GAD65/67 mRNAs but normal densities of GABAergic interneurons in the brain regions of Shank3-overexpressing manic mouse model.
Lee B; Zhang Y; Kim Y; Kim S; Lee Y; Han K
Neurosci Lett; 2017 May; 649():48-54. PubMed ID: 28400125
[TBL] [Abstract][Full Text] [Related]
16. Brain region-specific disruption of Shank3 in mice reveals a dissociation for cortical and striatal circuits in autism-related behaviors.
Bey AL; Wang X; Yan H; Kim N; Passman RL; Yang Y; Cao X; Towers AJ; Hulbert SW; Duffney LJ; Gaidis E; Rodriguiz RM; Wetsel WC; Yin HH; Jiang YH
Transl Psychiatry; 2018 Apr; 8(1):94. PubMed ID: 29700290
[TBL] [Abstract][Full Text] [Related]
17. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation.
Li JG; Haines DS; Liu-Chen LY
Mol Pharmacol; 2008 Apr; 73(4):1319-30. PubMed ID: 18212250
[TBL] [Abstract][Full Text] [Related]
18. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Komander D; Lord CJ; Scheel H; Swift S; Hofmann K; Ashworth A; Barford D
Mol Cell; 2008 Feb; 29(4):451-64. PubMed ID: 18313383
[TBL] [Abstract][Full Text] [Related]
19. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.
Yamashita S; Matsuo Y; Tawara N; Hara K; Yamamoto M; Nishikami T; Kawakami K; Zhang X; Zhang Z; Doki T; Ando Y
Sci Rep; 2019 Aug; 9(1):11606. PubMed ID: 31406156
[TBL] [Abstract][Full Text] [Related]
20. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.
Zhu G; Herlyn M; Yang X
Nat Cell Biol; 2021 Sep; 23(9):978-991. PubMed ID: 34497368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
